Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma. (2022)

First Author: Spiliopoulou P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-21-0743

PubMed Identifier: 35131874

Publication URI: http://europepmc.org/abstract/MED/35131874

Type: Journal Article/Review

Volume: 21

Parent Publication: Molecular cancer therapeutics

Issue: 4

ISSN: 1535-7163